MTF2
Basic information
Region (hg38): 1:93079235-93139079
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 15 | 0 | 1 |
Variants in MTF2
This is a list of pathogenic ClinVar variants found in the MTF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-93110243-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
1-93110247-G-C | not specified | Uncertain significance (Aug 09, 2021) | ||
1-93110261-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
1-93110373-A-G | not specified | Uncertain significance (Apr 08, 2022) | ||
1-93115020-G-C | not specified | Uncertain significance (Dec 20, 2021) | ||
1-93115023-T-A | not specified | Uncertain significance (May 29, 2024) | ||
1-93115077-A-T | not specified | Uncertain significance (Dec 19, 2022) | ||
1-93118449-G-A | Benign (Feb 12, 2018) | |||
1-93120560-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
1-93133724-A-C | not specified | Uncertain significance (May 13, 2024) | ||
1-93133783-T-A | not specified | Uncertain significance (Oct 28, 2024) | ||
1-93133940-A-G | not specified | Likely benign (Oct 22, 2024) | ||
1-93133949-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
1-93133977-T-C | not specified | Uncertain significance (Mar 29, 2022) | ||
1-93134110-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
1-93134120-A-G | not specified | Uncertain significance (Nov 19, 2024) | ||
1-93134131-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
1-93134152-A-G | not specified | Uncertain significance (Jun 22, 2024) | ||
1-93136695-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
1-93136749-C-A | not specified | Uncertain significance (May 14, 2024) | ||
1-93136802-T-G | not specified | Uncertain significance (Apr 03, 2023) | ||
1-93136828-A-G | not specified | Uncertain significance (Jan 08, 2024) | ||
1-93136951-G-A | not specified | Uncertain significance (Jan 25, 2024) | ||
1-93136984-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
1-93136998-G-A | not specified | Uncertain significance (Sep 01, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTF2 | protein_coding | protein_coding | ENST00000370298 | 15 | 59847 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000132 | 125637 | 0 | 2 | 125639 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.55 | 189 | 316 | 0.597 | 0.0000160 | 3871 |
Missense in Polyphen | 18 | 90.259 | 0.19943 | 1129 | ||
Synonymous | -0.0634 | 105 | 104 | 1.01 | 0.00000495 | 1086 |
Loss of Function | 5.11 | 2 | 34.3 | 0.0584 | 0.00000168 | 446 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000935 | 0.00000880 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Polycomb group (PcG) that specifically binds histone H3 trimethylated at 'Lys-36' (H3K36me3) and recruits the PRC2 complex. Acts by binding to H3K36me3, a mark for transcriptional activation, and recruiting the PRC2 complex, leading to enhance PRC2 H3K27me3 methylation activity. Regulates the transcriptional networks during embryonic stem cell self-renewal and differentiation. Promotes recruitment of the PRC2 complex to the inactive X chromosome in differentiating XX ES cells and PRC2 recruitment to target genes in undifferentiated ES cells. Required to repress Hox genes by enhancing H3K27me3 methylation of the PRC2 complex. In some conditions may act as an inhibitor of PRC2 activity: able to activate the CDKN2A gene and promote cellular senescence by suppressing the catalytic activity of the PRC2 complex locally. Binds to the metal-regulating-element (MRE) of MT1A gene promoter (By similarity). {ECO:0000250}.;
- Pathway
- Mesodermal Commitment Pathway;Interactome of polycomb repressive complex 2 (PRC2);Copper homeostasis;Epigenetic regulation of gene expression;Gene expression (Transcription);PRC2 methylates histones and DNA
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.311
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.54
Haploinsufficiency Scores
- pHI
- 0.935
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.674
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.781
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mtf2
- Phenotype
- cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;chromatin organization;segment specification;stem cell population maintenance;negative regulation of gene expression, epigenetic;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;stem cell differentiation;negative regulation of histone H3-K27 methylation;positive regulation of histone H3-K27 methylation;cellular response to leukemia inhibitory factor
- Cellular component
- nucleus;nucleoplasm;cytoplasm;focal adhesion;ESC/E(Z) complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity;nucleosome binding;methylated histone binding;sequence-specific DNA binding;metal ion binding